Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis

por Akgün, Katja, Blankenburg, Judith, Marggraf, Michaela, Haase, Rocco, Ziemssen, Tjalf
Publicado 2020

Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls

por Räuber, Saskia, Nelke, Christopher, Schroeter, Christina B., Barman, Sumanta, Pawlitzki, Marc, Ingwersen, Jens, Akgün, Katja, Günther, Rene, Garza, Alejandra P., Marggraf, Michaela, Dunay, Ildiko Rita, Schreiber, Stefanie, Vielhaber, Stefan, Ziemssen, Tjalf, Melzer, Nico, Ruck, Tobias, Meuth, Sven G., Herty, Michael
Publicado 2023